Gammagard and Myasthenia gravis aggravated - a phase IV clinical study of FDA data

Summary:

Myasthenia gravis aggravated is reported as a side effect among people who take Gammagard (immune globulin), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Mestinon, and have Primary immunodeficiency syndrome.

The phase IV clinical study analyzes which people have Myasthenia gravis aggravated when taking Gammagard. It is created by eHealthMe based on reports of 8,933 people who have side effects when taking Gammagard from the FDA, and is updated regularly.

What is Gammagard?

Gammagard has active ingredients of immune globulin. eHealthMe is studying from 8,948 Gammagard users. Check the latest studies of Gammagard.

What is Myasthenia gravis aggravated?

Myasthenia gravis aggravated (a chronic condition that causes muscles to tire and weaken easily) is found to be associated with 504 drugs and 381 conditions by eHealthMe. Check the latest studies of Myasthenia gravis aggravated.

On Jul, 23, 2026

8,933 people reported to have side effects when taking Gammagard.
Among them, 42 people (0.47%) have Myasthenia gravis aggravated.

Could Gammagard cause Myasthenia gravis aggravated?

Among these 42 people:

How long have people been on Gammagard when they have Myasthenia gravis aggravated? *

What is the gender of people who have Myasthenia gravis aggravated when taking Gammagard? *

female: 80 %
male: 20 %

What is the age of people who have Myasthenia gravis aggravated when taking Gammagard? *

What are other drugs people take besides Gammagard? *

What are other side effects people have besides Myasthenia gravis aggravated? *

Fatigue (feeling of tiredness): 18 people, 42.86%
Fall: 16 people, 38.10%
Dyspnea (difficult or laboured breathing): 15 people, 35.71%
Urinary Tract Infection: 14 people, 33.33%
Nausea (feeling of having an urge to vomit): 14 people, 33.33%
Headache (pain in head): 13 people, 30.95%
Weakness: 13 people, 30.95%
Pain: 12 people, 28.57%
Joint Injury: 10 people, 23.81%
Sinusitis (inflammation of sinus): 9 people, 21.43%

What are the existing conditions these people have? *

Primary Immunodeficiency Syndrome: 12 people, 28.57%
Immunodeficiency Common Variable: 11 people, 26.19%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 2 people, 4.76%
Secondary Immunodeficiency (lack of immunity due to some disease): 1 person, 2.38%
Nausea (feeling of having an urge to vomit): 1 person, 2.38%
Myasthenia Gravis Crisis (a paralysis of the respiratory muscles occurs): 1 person, 2.38%
Lambert-Eaton Syndrome (this means your immune system mistakenly targets healthy cells and tissues in the body): 1 person, 2.38%

* Approximation only. Some reports may have incomplete information.

Do you take Gammagard and have Myasthenia gravis aggravated?

- Check whether Myasthenia gravis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gammagard:

Gammagard (8,948 reports)

Browse all side effects of Gammagard:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Myasthenia gravis aggravated:

Myasthenia gravis aggravated (504 drugs)

Browse all the conditions that are associated with Myasthenia gravis aggravated:

Myasthenia gravis aggravated (381 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on immune globulin (the active ingredients of Gammagard) and Gammagard (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.